CNBX Pharms Stock Price, News & Analysis

CNBX OTC Link

Company Description

Welcome to the overview page for CNBX Pharms (CNBX), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-98.68%

Performance 1 year

$27.8K

Market Cap

870.8M

Shares outstanding

Latest News

View All

November 8, 2022

+0.76%

CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma

acquisition

October 18, 2022

-8.51%

CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy

October 13, 2022

+19.69%

CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel

clinical trial

September 29, 2022

+3.58%

CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate

September 28, 2022

+7.14%

CNBX Pharmaceuticals Announces New Patent Granted in Australia

May 5, 2022

+6.33%

CNBX Pharmaceuticals Granted Patent in Hong Kong

SEC Filings

View All

February 5, 2026

[SCHEDULE 13G/A] 3i details large CNBX Pharmaceuticals (CNBX) position through convertible note

January 14, 2026

[10-Q] CNBX Pharmaceuticals (OTCQB: CNBX) Q1 loss widens as cash and equity shrink

December 1, 2025

[10-K] CNBX Pharmaceuticals Inc. Files Annual Report

November 10, 2025

[SCHEDULE 13G/A] 3i, LP discloses 80,865,244 CNBX shares—9.99% ownership stake

Financial Highlights

View Full Financials

Revenue (TTM)

-$314K

Net Income (TTM)

$0.00

Diluted EPS (TTM)

-$171K

Operating Cash Flow

0.01

Current Ratio

-$272K

Operating Income

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Short interest in CNBX Pharms (CNBX) currently stands at 75.0 thousand shares, down 25.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 35.5%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Loading days to cover data...

Days to cover for CNBX Pharms (CNBX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.